Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02808897Not ApplicableCompleted

Active Clearance of Chest Tubes After Cardiac Surgery: A Prospective Randomized Controlled Study

Role: collaborator

NCT02145858Completed

Prevention of Retained-Blood Outcomes With Active Clearance Technology

Role: lead

NCT02479737Unknown

Active Clearance Technology (ACT) II German Multicenter Trial

Role: collaborator

All 3 trials loaded